Eisai Says First-Half Profit Fell 17% to 33.3 Billion Yen

Eisai Co., the maker of the Aricept treatment for Alzheimer’s disease, reported first-half profit fell 17 percent to 33.3 billion yen in a statement to the Tokyo Stock Exchange today.

Before it's here, it's on the Bloomberg Terminal. LEARN MORE